No Data
Robust Healthcare: 2024 Semi-Annual Report Summary
Robust Healthcare: Semi-Annual Report 2024
Winner Medical (300888.SZ): The net income in the first half of the year is 0.384 billion yuan, and it is planned to distribute a dividend of 4 yuan.
Winner Medical (300888.SZ) announced its interim report for the first half of 2024, with operating revenue of 4.034 billion yuan, a decrease of 5.47% YoY; net profit attributable to shareholders of listed companies was 0.384 billion yuan, a decrease of 43.64% YoY; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 0.327 billion yuan, a decrease of 40.57% YoY; basic earnings per share was 0.6568 yuan; cash dividends of 4.00 yuan per 10 shares (including tax) are proposed to be distributed to all shareholders.
Be Wary Of Winner Medical (SZSE:300888) And Its Returns On Capital
Non-Silver Antimicrobial Dressings Market Research 2023-2030 Featuring Cardinal Health, Essity, Winner Medical, Medline, DeRoyal, Smith & Nephew, L&R, Organogenesis, ConvaTec, Kane Biotech - ResearchAndMarkets.com
Is Winner Medical Co., Ltd.'s (SZSE:300888) Stock Price Struggling As A Result Of Its Mixed Financials?
Winner Medical Co., Ltd.'s (SZSE:300888) Price Is Right But Growth Is LackingNo Data
No Data
